Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2012
12/19/2012EP2535352A1 Pharmaceutical compound with antibodies against catalase and superoxide dismutase for tumour treatment
12/19/2012EP2535351A2 Dual specificity antibody fusions
12/19/2012EP2535350A1 Dual specificity antibody fusions
12/19/2012EP2535349A1 Dual specificity antibody fusions
12/19/2012EP2535333A1 Generically binding antibodies with multiple applications
12/19/2012EP2534257A2 Methods for identifying and isolating cells expressing a polypeptide
12/19/2012EP2534179A2 Upar binding agents and methods of use thereof
12/19/2012EP2534178A1 Therapeutic methods using an ti-cd200 antibodies
12/19/2012EP2534177A2 Antibodies against cxcr4
12/19/2012EP2534176A1 Agonist dr5 binding polypeptides
12/19/2012EP2534175A2 Treatment of a metabolic disorder
12/19/2012EP2534174A1 Preparation and/or purification of oligonucleotide conjugates
12/19/2012EP2534169A1 Single unit antibody purification
12/19/2012EP2533814A2 Delivery of immunoglobulin variable domains and constructs thereof
12/19/2012EP2533811A2 Multimeric proteins comprising immunoglobulin constant domains
12/19/2012EP2533810A1 Cd20 antibodies and uses thereof
12/19/2012EP2533804A1 Antibody drug conjugates (adc) that bind to 161p2f10b proteins
12/19/2012CN1947018B Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination
12/19/2012CN102834720A Diagnosis of gluten-induced autoimmune diseases
12/19/2012CN102834414A Antibodies against csf-1r
12/19/2012CN102834413A Treatment of a metabolic disorder
12/19/2012CN102834412A Integrin avss8 neutralizing antibody
12/19/2012CN102834407A Filler for affinity chromatography
12/19/2012CN102834113A Pharmaceutical composition for treating and/or preventing cancer
12/19/2012CN102830225A Hemagglutinin and immunizing antigen from naturally avirulent strain of avian influenza virus
12/19/2012CN102827813A Anti-human CD133 monoclonal antibody and preparation method and applications thereof
12/19/2012CN102827283A Transgenic non-human animals capable of producing heterologous antibodies
12/19/2012CN102827282A Human resistant Trop-2 genetically engineered antibody immunoglobulin G (IgG) and application thereof
12/19/2012CN102827281A Monoclonal antibody against CD2 protein and application thereof
12/19/2012CN102827280A Anti-IL-13 antibodies and use thereof
12/19/2012CN102827279A Anti-neuroepithelial stem cell protein monoclonal antibody with high titer and high specificity and application thereof
12/19/2012CN102827278A Antitumor protein P53 monoclonal antibody and application thereof
12/19/2012CN102827277A Anti-human serum albumin single-chain antibody and method for connecting polypeptide drugs to carbon end thereof
12/19/2012CN102827276A Antibody of cytochrome b5 type B and application thereof in purifying mitochondria
12/19/2012CN102827275A Method for preparing duck virus hepatitis divalent refined egg yolk antibody
12/19/2012CN102827274A Hepatitis B vaccine antibody and chip containing antibody
12/19/2012CN102827273A Preparation of vaccinia virus (VACA) resistant egg yolk antibody (IgY)
12/19/2012CN102827272A Folate coupling antibody drug and its preparation method and use
12/19/2012CN102827222A Hapten, artificial antigen and monoclonal antibody for tylosin and preparation methods and applications thereof
12/19/2012CN102827076A Universal hapten of fluoroquinolone medicines, artificial antigen, broad-spectrum monoclonal antibody, preparation method and application
12/19/2012CN102827054A Hapten of L-hydroxyproline, artificial antigen, monoclonal antibody, preparation method and application
12/19/2012CN102188449B Preparation method of high-immune whole-egg powder for resisting piglet diarrhea
12/19/2012CN102040658B Schistosoma japonica polypeptide with immunogenicity and application thereof
12/19/2012CN101974535B Preparation and application of novel anti-ErbB2 humanized antibody MIL12
12/19/2012CN101948537B Method for extracting chicken yolk antibody against infectious bursal disease
12/19/2012CN101679968B Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
12/19/2012CN101437540B Melanocortin receptor binding mimetibodies, compositions, methods and uses
12/19/2012CN101001874B Poly-n-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
12/18/2012US8334367 T2R taste receptors and genes encoding same
12/18/2012US8334253 Cosmetic and dermatological formulations of MNTF peptides
12/18/2012US8334146 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/18/2012US8334118 Enzymes having alpha amylase activity and methods of making and using them
12/18/2012US8334102 Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes
12/18/2012US8333995 Protein microspheres having injectable properties at high concentrations
12/18/2012US8333972 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
12/18/2012US8333967 Anti-Aβ oligomer humanized antibody
12/18/2012US8333965 Anti-inteferon alpha monoclonal antibodies and methods for use
12/18/2012US8333964 ErbB antagonists for pain therapy
12/18/2012US8333963 Method of inhibiting osteoclast activity
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2589421C Erbb3 antibodies
12/18/2012CA2524002C Sars-related proteins
12/18/2012CA2519059C Physiologically active polypeptide conjugate having prolonged in vivo half-life
12/18/2012CA2501864C Methods and systems for detecting mhc class i and class ii binding peptides
12/18/2012CA2489275C Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests for diagnosis and management of aisnhl
12/18/2012CA2466034C Stable aqueous pharmaceutical formulations of daclizumab antibodies
12/18/2012CA2460468C Novel polypeptide, dna thereof and use of the same
12/18/2012CA2445537C Antigen targeting
12/18/2012CA2436057C A method for identification, isolation and production of antigens to a specific pathogen
12/18/2012CA2407895C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
12/18/2012CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
12/18/2012CA2375269C A method of prophylaxis and treatment and agents useful for same
12/18/2012CA2363486C Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
12/13/2012WO2012170669A1 Biomarkers for assessment of the molecular quality in biospecimens
12/13/2012WO2012170607A2 Use of pcsk9 antagonists
12/13/2012WO2012170470A1 Compositions and methods for detection and treatment of cancer
12/13/2012WO2012170071A1 Mcam antagonists and methods of treatment
12/13/2012WO2012169970A1 Purification of biological products by constrained cohydration chromatography
12/13/2012WO2012169741A2 Fcεri-specific human antibody and composition comprising same for treating or diagnosing allergic diseases
12/13/2012WO2012169200A1 Sema5b peptides and vaccines including the same
12/13/2012WO2012168491A1 Pharmaceutical formulations of pcsk9 antagonists
12/13/2012WO2012168486A1 Cetp fragments
12/13/2012WO2012168344A1 BINDING COMPOUNDS TO HUMAN β1-ADRENORECEPTOR (β1-AR) AND THEIR USE IN THE MEASUREMENT OF AUTO-ANTI-βA1-AR ANTIBODIES
12/13/2012WO2012168259A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer
12/13/2012WO2012168199A1 Therapeutic antibodies
12/13/2012WO2012167887A1 Diagnostic use of prosomatostatin
12/13/2012WO2012167346A1 Anti-ricin antibodies and uses thereof
12/13/2012WO2012143499A3 Novel binder-drug conjugates (adcs) and their use
12/13/2012WO2012143495A3 Novel binder-drug conjugates (adcs) and their use
12/13/2012WO2012142286A8 Methods for suppressing allergic reactions
12/13/2012WO2012135671A3 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
12/13/2012US20120317678 Gene Dro1 Controlling Deep-Rooted Characteristics of Plant and Utilization of Same
12/13/2012US20120316324 Disulfide Stabilised Multivalent Antibodies
12/13/2012US20120316323 New process for the industrial-scale purification of gamma globulins from human plasma for industrial applications
12/13/2012US20120316319 Arylethynylxanthene dyes
12/13/2012US20120316085 Antibody humanization by framework assembly
12/13/2012US20120315701 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same
12/13/2012US20120315686 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
12/13/2012US20120315655 Biomarkers of musculoskeletal disease
12/13/2012US20120315644 Anti-npc2 monoclonal antibodies and a method of detecting fatty liver tissue, cancer cells or cancer tissue by using them
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 1494